Route of Indian COVID vaccine?

SGPGI Nursing Officer-2023

Pharmacology

Easy

Appeared in: SGPGI Nursing Officer-2023

Explanation

The primary Indian COVID-19 vaccines, Covaxin (inactivated virus) and Covishield (viral vector), are administered via the Intramuscular (IM) route.
The IM route is chosen because muscle tissue has a rich blood supply that helps in the efficient uptake of the vaccine by immune cells (antigen-presenting cells).
This leads to a robust and systemic immune response, which is crucial for the efficacy of these vaccines.
The standard site for administration in adults is the deltoid muscle in the upper arm.

Option B: Intravenous (IV) administration introduces substances directly into the bloodstream for rapid systemic effect. This route is not used for vaccines like Covishield or Covaxin because it bypasses the necessary local immune processing in the muscle tissue, which is essential for developing a strong immune memory.
Option C: Intradermal (ID) injections are given into the dermis, the layer of skin just beneath the epidermis. This route is not indicated for Indian COVID vaccines. It is used for substances where a slow absorption and a local reaction are desired, such as in sensitivity testing.
Option D: Subcutaneous (SC) injections are administered into the fatty tissue under the skin. This route provides slower absorption than IM injections. While some vaccines use this route, it is not the recommended route for Covishield or Covaxin, as it may lead to a less effective immune response and potentially more local irritation.

Clinical Relevance

Nursing practice connection: This is primarily an exam-oriented knowledge point with limited direct bedside application, so retain Route of Administration for Vaccines as background academic context rather than a clinical decision trigger.
Using the correct administration route is critical for vaccine efficacy and safety. An incorrect route can lead to a suboptimal immune response, rendering the patient unprotected, or cause increased local adverse reactions.
Nurses must be vigilant in following manufacturer guidelines and standard protocols for every injection to ensure patient safety and public health effectiveness.
What if? If a vaccine designed for IM administration is accidentally given subcutaneously, the immune response may be weaker, and there could be a higher risk of local reactions like inflammation or nodule formation because the vaccine's adjuvant may be more irritating to fatty tissue.

How to Approach the Question

First, identify the key terms in the question: 'Route' and 'Indian COVID vaccine'.
This is a factual recall question based on standard immunization protocols.
Recall the specific administration guidelines for the major vaccines used in India's COVID-19 vaccination program (Covishield and Covaxin).
Consider the different parenteral routes (IM, IV, ID, SC) and their general purposes.
Select the option that matches the established protocol for these specific vaccines, which is Intramuscular (IM).

Concept Tested & Keywords

QhC5rdvkb_cOo_3bGYAAH3

E6 Pharmacology KD Tripathi Essentials 9e Part 3 p. 289-291

E6 Ghai Essential Pediatrics(pp 26-904 of 913) p. 187-189

E6 Parks TextBook of Preventive & Social Medicine part 1 — Subpart A (pp 26-201 of 604) p. 99-101